
Keywords: پاسخ پایدار ویروسی; Liver Transplantation; HCC; Cholabgiocarcinoma; Machine Perfusion; Hepatitis C; AASLD; American Association for the Study of Liver Diseases; BAR; balance of risk; D-MELD; donor age à recipient Model of End-Stage Liver Disease; DCC; distal cholangiocarci